ArticleNaunyn-Schmiedeberg's archives of pharmacology2013

Interaction of D₃ preferring agonist (-)-N⁶-(2-(4-(biphenyl-4-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264) with cloned human D₂L, D₂S, and D₃ receptors: potent stimulation of mitogen-activated protein kinases and G protein-coupled inward rectifier potassium channels.

Eldo V Kuzhikandathil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.